psychedelics

Latest

psychedelics

Featured Neuroscience Open Neuroscience Articles Psychology

·June 5, 2020

Psychedelic drug psilocybin tamps down brain’s ego center

Psilocybin reduces activity in the claustrum, an area of the brain believed to contribute to consciousness and sense of self. Researchers say the reduced activity may tie in with the reduced sense of self and ego often associated with psychedelic drug use. The study also reports psilocybin alters the way the claustrum communicates with brain areas involved in attention, decision making, auditory processing, and memory. Read More

Featured Neuroscience Open Neuroscience Articles

·April 16, 2020

Neuronal and neurotransmitter systems dynamic coupling explains the effects of psilocybin

Computational simulations reveal the integration of both neuronal and neurotransmitter systems at a whole-brain level is vital to fully understand the effects of psilocybin on brain activity. Read More

Featured Neuroscience Psychology

·March 30, 2020

The placebo effect and psychedelic drugs: tripping on nothing?

Is it possible to have a psychedelic experience from taking a placebo alone? A new study says it is. Read More

Featured Neurology Neuroscience pain Psychology

·February 28, 2020

Overdosing on psychedelics improved mental and physical health: Case studies

A recent case study report highlights the effects of LSD overdoses on three women, revealing the subjects experienced improvements in physical and mental health following their overdoses. Read More

This shows a brain and a swirly background

Brain Cancer Featured Neuroscience Psychology

·February 2, 2020

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

A single dose of the psychedelic psilocybin reduces depression, anxiety, and feelings of hopelessness in cancer patients for 12 months after the drug is administered. Read More

This shows a psychedelic face and flowers

Featured Neuroscience Psychology

·January 28, 2020

Could psychedelics help treat mental health and resolve the climate crisis?

Numerous recent studies claim psychedelics, such as psilocybin, can help treat a range of mental health problems from depression to PTSD. Researchers investigate how psychedelics can help us become more "nature-connected" and increase a sense of environmental responsibility. Read More

This shows two heads and a swirly background

Featured Neuroscience Psychology

·January 20, 2020

New research confirms lingering mood benefit of psychedelics

Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness, after the effect of the drug has worn off. Read More

This shows psychedelic swirls around a person's head

Featured Neuroscience Psychology

·January 17, 2020

Psychedelic drugs could help treat PTSD

Backing up previous research, a new study reveals psychedelics can have beneficial effects for treating PTSD when combined with traditional trauma-focused psychotherapy. Findings suggest MDMA assisted therapy is significantly more effective at treating patients with persistent PTSD than psychotherapy alone. Read More

Featured Neuroscience Open Neuroscience Articles

·November 21, 2019

Could psychedelic drugs be a new treatment option for people with depression?

Study discussed the benefits of using psychedelics as an antidepressant option for those with depression. Read More

This shows a person in the lotus position with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·October 24, 2019

Mindfulness meditation enhances positive effects of psilocybin

Mindful meditation enhances the positive effects of a single dose of psilocybin by increasing empathy and reducing egocentricity. Read More

Featured Neuroscience Psychology

·September 1, 2019

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'. Read More

This shows a woman paining the face of another woman on a wall

Featured Neuroscience Psychology

·August 22, 2019

‘Microdosers’ of psychedelics report improved mood, focus and creativity

Those who microdose psychedelics report improved mood, greater focus, and increased creativity. A new study looks at the positive outcomes of microdosing and suggests others look at potential long-term negative consequences of using psychedelics. Read More

1 2 3 4